Copyright Reports & Markets. All rights reserved.

Global CAR T-Cell Therapy for Multiple Myeloma Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by CAR T-Cell Therapy for Multiple Myeloma Revenue
  • 1.4 Market by Type
    • 1.4.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Monotherapy
    • 1.4.3 Combination Therapy
  • 1.5 Market by Application
    • 1.5.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Application: 2020 VS 2026
    • 1.5.2 Multiple Myeloma
    • 1.5.3 Refractory or Relapsed Multiple Myeloma
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Perspective (2015-2026)
  • 2.2 Global CAR T-Cell Therapy for Multiple Myeloma Growth Trends by Regions
    • 2.2.1 CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 CAR T-Cell Therapy for Multiple Myeloma Historic Market Share by Regions (2015-2020)
    • 2.2.3 CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 CAR T-Cell Therapy for Multiple Myeloma Market Growth Strategy
    • 2.3.6 Primary Interviews with Key CAR T-Cell Therapy for Multiple Myeloma Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top CAR T-Cell Therapy for Multiple Myeloma Players by Market Size
    • 3.1.1 Global Top CAR T-Cell Therapy for Multiple Myeloma Players by Revenue (2015-2020)
    • 3.1.2 Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Concentration Ratio
    • 3.2.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy for Multiple Myeloma Revenue in 2019
  • 3.3 CAR T-Cell Therapy for Multiple Myeloma Key Players Head office and Area Served
  • 3.4 Key Players CAR T-Cell Therapy for Multiple Myeloma Product Solution and Service
  • 3.5 Date of Enter into CAR T-Cell Therapy for Multiple Myeloma Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global CAR T-Cell Therapy for Multiple Myeloma Historic Market Size by Type (2015-2020)
  • 4.2 Global CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)
  • 5.2 Global CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2020)
  • 6.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in North America (2019-2020)
  • 6.3 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
  • 6.4 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2020)
  • 7.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Europe (2019-2020)
  • 7.3 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
  • 7.4 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)

8 China

  • 8.1 China CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2020)
  • 8.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in China (2019-2020)
  • 8.3 China CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
  • 8.4 China CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2020)
  • 9.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Japan (2019-2020)
  • 9.3 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
  • 9.4 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2020)
  • 10.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
  • 10.4 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)

11 India

  • 11.1 India CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2020)
  • 11.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in India (2019-2020)
  • 11.3 India CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
  • 11.4 India CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2020)
  • 12.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
  • 12.4 Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Juno Therapeutics
    • 13.1.1 Juno Therapeutics Company Details
    • 13.1.2 Juno Therapeutics Business Overview
    • 13.1.3 Juno Therapeutics CAR T-Cell Therapy for Multiple Myeloma Introduction
    • 13.1.4 Juno Therapeutics Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020))
    • 13.1.5 Juno Therapeutics Recent Development
  • 13.2 Kite Pharma
    • 13.2.1 Kite Pharma Company Details
    • 13.2.2 Kite Pharma Business Overview
    • 13.2.3 Kite Pharma CAR T-Cell Therapy for Multiple Myeloma Introduction
    • 13.2.4 Kite Pharma Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020)
    • 13.2.5 Kite Pharma Recent Development
  • 13.3 Novartis
    • 13.3.1 Novartis Company Details
    • 13.3.2 Novartis Business Overview
    • 13.3.3 Novartis CAR T-Cell Therapy for Multiple Myeloma Introduction
    • 13.3.4 Novartis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020)
    • 13.3.5 Novartis Recent Development
  • 13.4 Collectis
    • 13.4.1 Collectis Company Details
    • 13.4.2 Collectis Business Overview
    • 13.4.3 Collectis CAR T-Cell Therapy for Multiple Myeloma Introduction
    • 13.4.4 Collectis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020)
    • 13.4.5 Collectis Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    CAR T-Cell Therapy for Multiple Myeloma market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global CAR T-Cell Therapy for Multiple Myeloma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Juno Therapeutics
    Kite Pharma
    Novartis
    Collectis
    ...

    Market segment by Type, the product can be split into
    Monotherapy
    Combination Therapy
    Market segment by Application, split into
    Multiple Myeloma
    Refractory or Relapsed Multiple Myeloma

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now